Search

Shop

Donate

Your heartHealthy livingFor professionalsResearchHow you can helpAbout us
Leveraging mRNA technology, this new kind of medicine rebuilds the heart-- growing new heart cells and reducing scarring to help people recover more fully from heart attacks.

Regenerating the heart after a heart attack

Catalyst Partnership Grants

/

Regenerating the heart after a heart attack

New life for scarred hearts

Leveraging mRNA technology to rebuild the heart

This new kind of medicine grows new heart cells and reduces scarring to help people recover more fully from heart attacks.

Catalyst heart

New life for scarred hearts

A new drug aims to heal heart attack damage by reducing scarring and regrowing heart muscle – offering hope for millions with heart disease.

Problem

Heart attacks leave scars that hearts can’t heal

Heart attacks kill heart muscle cells, which the body cannot regenerate. These dead cells are replaced with non-functional scar tissue that can’t contract or pump blood properly, leading to long-term heart damage and heart failure in about a third of patients.

Current treatments only help reduce strain on the heart or prevent further attacks, but none restore lost heart tissue, leaving millions of people with lifelong complications and an uncertain future.

Solution

First-of-its-kind treatment to regenerate heart muscle

This project is developing a first-in-class, minimally invasive, injectable therapy that reprograms scar tissue into healthy, functioning heart muscle.

The therapy uses messenger RNA (mRNA) — the same type of technology used in COVID-19 vaccines — to send healing instructions directly into the heart. These instructions are carried in tiny particles called lipid nanoparticles (LNPs), which help safely deliver the message to specific heart cells and activate only where needed.

The project brings together cutting-edge breakthroughs in advanced gene science (mRNA), delivery technology (LNPs), and heart cell mapping (single-cell genomics) to help ensure the treatment is safe, targeted, and effective.

The team has already demonstrated that their therapy can successfully reach and enter damaged heart tissue using in vitro models - a critical step toward regenerating the heart after a heart attack.

This groundbreaking approach could regenerate heart muscle in ways once thought impossible - offering hope to millions living with the long-term effects of heart damage.

Impact

Restoring hearts. Reducing deaths. Rewriting futures

This therapy has the potential to help every heart attack survivor by aiding recovery, preventing heart failure, and reducing the risk of death. Additionally, it could reduce hospitalisations and improve recovery outcomes and increase equity of access through a non-surgical approach.

By regenerating the heart, we are not just treating the symptoms of heart attacks – we are offering a true second chance at life.

Image with a light gray background featuring a red heart outline with a plus sign inside it on the left. To the right, black text reads: 'Regenerating the heart will transform the lives of heart attack victims and generate substantial economic benefits through decreased hospitalisations and increased workforce productivity.

Meet the team

Prof Peter Meikle

Prof Peter Meikle

Project Lead, Baker Heart and Diabetes Institute

Prof Hans Schneider

Prof Hans Schneider

Pathology Lead, Alfred Pathology

Prof Tom Marwick

Prof Tom Marwick

Clinical Advisor, Baker Heart and Diabetes Institute

Bruce Neal

Prof Bruce Neal

Executive Director, The George Institute

A/Prof Melinda Carrington

A/Prof Melinda Carrington

Clinical Implementation, Baker Heart and Diabetes Institute

Prof Gemma Figtree

Prof Gemma Figtree

National Translation Partner, University of Sydney

Prof Alex Brown

Prof Alex Brown

Indigenous Health Lead, Australian National University

Prof Dianna Magliano OAM

Prof Dianna Magliano OAM

Epidemiology Lead, Baker Heart and Diabetes Institute

Prof Paul Scuffham

Prof Paul Scuffham

Health Economics Lead, Griffith University

Dr Thomas Meikle

Dr Thomas Meikle

Health Economics Lead, Griffith University

blank

Dr Jingqin Wu

Metabolomics, Bioinformatician, Baker Heart and Diabetes Institute

blank

Dr Tingting Wang

Metabolomics, Bioinformatician, Baker Heart and Diabetes Institute

blank

Dr Aleks Dakic

Metabolomics, Post-doctoral Bioinformatician, Baker Heart and Diabetes Institute

blank

Dr Kevin Huynh

Group leader, Metabolomics, Baker Heart and Diabetes Institute

blank

Dr Corey Giles

Post-doctoral researcher, Baker Heart and Diabetes Institute

Supported by

Baker Heart & Diabetes Institute

Alex Pinto

The technology to accomplish this project has only emerged in the past few years. We have an historic opportunity to combine these new technologies and develop a drug that changes the paradigm on how we treat people who have a heart attack - making heart failure resulting from heart attacks a thing of the past.

Alex Pinto

Project Lead

You might also be interested in...

A man discussing his health concerns with a doctor while seated on a couch.
What is a heart attack?

A heart attack is a medical emergency. Learn the key signs, causes, and treatment options to protect your heart and act quickly when every second counts.

key-statistics-heart-attack
Key statistics: Heart attack

Statistics and information on heart attack in Australia

A new therapeutic ‘molecular glue’ that helps seal and repair one of the earliest changes in Alzheimer’s disease
Mending our blood vessels to combat dementia

A new therapeutic ‘molecular glue’ that helps seal and repair one of the earliest changes in Alzheimer’s disease¬¬¬¬¬¬¬¬¬¬¬¬¬¬ - leaky blood vessels in the brain - preventing disease progression before it’s too late.

Keep up to date with heart health tips, healthy recipes & latest news

The Heart Foundation acknowledges the Traditional Owners and Custodians of Country throughout Australia and their continuing connection to land, waters and community. We pay our respect to them and their cultures, and Elders past, present and emerging.

AboutBoard and governanceOur vision and strategyJoin our team
Privacy PolicyTermsMerchandise Policy

Heart Foundation is a registered charity

© 2025 National Heart Foundation of Australia ABN 98 008 419 761